Nippon Shinyaku Co., Ltd. (OTCMKTS:NPNKF – Get Free Report) was the target of a significant decrease in short interest in October. As of October 15th, there was short interest totaling 149,007 shares, a decrease of 59.7% from the September 30th total of 369,872 shares. Based on an average trading volume of 964 shares, the days-to-cover ratio is currently 154.6 days.
Nippon Shinyaku Stock Performance
Shares of NPNKF remained flat at $23.12 during trading hours on Friday. Nippon Shinyaku has a 1-year low of $23.10 and a 1-year high of $32.00. The firm has a 50 day simple moving average of $23.37 and a 200 day simple moving average of $29.04.
Nippon Shinyaku Company Profile
Nippon Shinyaku Co, Ltd. is a Japan-based pharmaceutical and food products company headquartered in Kyoto. Founded in 1919, the company develops, manufactures and markets prescription medicines, with a focus on specialty treatments in areas such as hematology, urology, oncology and rare diseases.
Nippon Shinyaku’s pharmaceutical portfolio includes therapies for blood disorders and other serious medical conditions. Through its U.S. subsidiary, NS Pharma, the company markets Viltepso (viltolarsen), an exon-skipping treatment for certain patients with Duchenne muscular dystrophy.
See Also
- Five stocks we like better than Nippon Shinyaku
- Starbucks Says Its Turnaround Is Done—The Numbers Make a Strong Case (With 1 Catch)
- 3 Robotics ETFs, 3 Different Ways to Bet on Humanoid Robots
- Can Microsoft Turn a Leaner Workforce and Record AI Spending Into Bigger Profits?
- Why JFrog Could Be the Software Infrastructure Company to Beat in the AI Boom
Receive News & Ratings for Nippon Shinyaku Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nippon Shinyaku and related companies with MarketBeat.com's FREE daily email newsletter.
